EUVIMEDEUVIMED entdecken
Crossref

STUDY OF HEMATOLOGICAL PARAMETERS IN DENGUE PATIENTS

Sumana Pawar

International Journal of Drug Delivery Technology · 17.06.2026 · 16 (54s)

DOI: 10.25258/ijddt.16.54s.73 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Sumana Pawar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dengue fever is a viral disease transmitted by mosquitoes which is a major public health problem in tropical and sub-tropical countries. Thrombocytopenia, leukopenia and increase in hematocrit are common hematological abnormalities among dengue patients, which are often associated with disease severity. These blood parameters are essential to monitor for early diagnosis, prognosis and clinical management of dengue infection.

Aim

The objective of this study was to study Blood Parameters and their relation with the severity of the disease and prognosis of Dengue. Methodology The secondary qualitative approach was taken and published journal articles and clinical studies from 2022 to 2025 were used. The data was retrieved from the academic databases such as PubMed, Wiley Online Library, and Heliyon. Studies related to the platelet count, white blood cell count, hematocrit and hemoglobin levels of dengue patients were reviewed and analysed.

Results

Results revealed that the most frequent hematological abnormality among dengue patients were thrombocytopenia. The platelet and white blood cell counts were significantly lower in severe cases of dengue, while hematocrit was higher in severe dengue cases. Mild abnormalities were seen in healthy children while severe abnormalities and slow recovery were seen in elderly and ill children.

Conclusion

Hematological parameters are useful indicators in order to assess the severity of dengue and to direct the patient management. Monitoring of blood parameters can help in early intervention, minimisation of complications and clinical outcomes in dengue cases.

Zitieren

APA

Pawar, S. (2026). STUDY OF HEMATOLOGICAL PARAMETERS IN DENGUE PATIENTS. International Journal of Drug Delivery Technology, 16(54s). https://doi.org/10.25258/ijddt.16.54s.73

Vancouver

Pawar S. STUDY OF HEMATOLOGICAL PARAMETERS IN DENGUE PATIENTS. International Journal of Drug Delivery Technology. 2026;16(54s). doi:10.25258/ijddt.16.54s.73

BibTeX
@article{Pawar2026,
  author = {Pawar, Sumana},
  title = {STUDY OF HEMATOLOGICAL PARAMETERS IN DENGUE PATIENTS},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {54s},
  doi = {10.25258/ijddt.16.54s.73}
}
Kostenlos starten →